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Abstract
Previous studies have shown a preferential loss of grey matter in fronto-temporal regions in patients with multiple
sclerosis. Studies of correlates of disease severity are more controversial, because some studies have suggested an
association between sensorimotor cortex atrophy and Expanded Disability Status Scale score, while others did not find
such a correlation. The objective of this study was to assess the correlation of regional loss of grey matter and white
matter with indexes of clinical and radiological severity in relapsing–remitting multiple sclerosis, including the Expanded
Disability Status Scale and lesion load. Correlations between Expanded Disability Status Scale, lesion load and disease
duration were assessed in 128 patients with relapsing–remitting multiple sclerosis (Expanded Disability Status Scale range
1.0–6.0) using optimized voxel-based morphometry. Bilateral loss of grey matter in sensorimotor cortices was correlated
with Expanded Disability Status Scale, and tissue loss also involved adjacent white matter, extending along pyramidal
tracts to the brainstem. Increasing lesion load was correlated with loss of deep grey matter and white matter. No specific
region of grey matter or white matter showed a significant correlation with disease duration. These findings support the
hypothesis that motor neuron involvement plays a major role in the progression of physical disability. Lesion load accrual
affects mainly highly interconnected subcortical structures, while disease duration has a less significant impact on brain
atrophy, probably owing to the inter-subject heterogeneity of the clinical course of the disease.
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Introduction
The results from previous studies of regional brain
tissue loss in multiple sclerosis (MS) suggest that grey
matter (GM) atrophy, in patients aﬀected by relapsing–
remitting (RR-)MS, is located preferentially in speciﬁc
regions of the brain, including motor areas
1,2 and
thalami.
3 Few studies have addressed the correlations
between regional brain atrophy and indexes of disease
severity, including disability and lesion load (LL), and
they provide somewhat conﬂicting results.
1,2,4–6
In particular Chen et al.
5 and Sailer et al.,
2 in two
small groups including both RR and secondary progres-
sive (SP-)MS patients, found a signiﬁcant thinning of the
motor areas in patients with more severe disability.
However, other studies focusing on RR-MS were not
able to detect signiﬁcant correlations between motor
cortex atrophy and clinical disability in small groups of
patients,
1,6 or in the early phases of the disease.
4
When assessing the relationship of atrophy with LL,
Sailer et al. found a signiﬁcant thinning of the prefron-
tal cortex in a subgroup of patients with higher LL, as
compared to the control group.
2 Charil et al. demon-
strated a preferential correlation of cortical thickness
with T2-LL in bilateral anterior cingulate gyrus,
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transverse temporal gyrus, right anterior and middle
temporal gyri and left inferior frontal and orbital
gyri.
4 Other groups have shown a signiﬁcant correla-
tion between LL and GM volume in the caudates,
1 the
frontal and parietal cortices in a longitudinal study,
7
and thalami in transversal studies.
6
All these attempts at correlating regional brain tissue
loss and disease severity have focused on GM volume
or cortical thinning, while correlates of regional white
matter (WM) volume have not been assessed, although
WM loss has been demonstrated in diﬀerent cohorts of
MS patients,
8,9 and may play a role in determining dis-
ease severity.
Voxel-based morphometry (VBM),
10 a fully auto-
mated technique used to assess the density of brain
tissues at a voxel level, has been applied previously to
assess the regional distribution of GM loss in RR-
MS,
1,3,6,7 and is suitable for the study of changes in
the volume of both GM and WM.
The aim of the present study was to assess the cor-
relation between regional losses of GM and WM and
indexes of disease severity, including clinical disability
(as measured by the Expanded Disability Status Scale,
EDSS) and LL, in a large group of patients with pure
RR-MS, using VBM.
Materials and methods
Participants
One-hundred and twenty-eight patients (86 female) with
MS, clinically deﬁned according to Poser criteria,
11 and
with an RR course
12 were recruited into the study. The
mean age of the patient group was 36.07 9.2 years
(range 18–58 years), with a mean disease duration
(DD) of 10.14 7.2 years (range 0.3–30.8 years) and
a median EDSS score of 2.8 (range 1.0–6.0).
13
The exclusion criteria for this study included treat-
ment with corticosteroids within the preceding 28 days,
previous treatment with cyclophosphamide, azathiopr-
ine, methotrexate, mithoxantrone or cyclosporine, or
previous treatment with any experimental immunomo-
dulating drug.
At the time of the scan 13 patients were drug naive,
while the remaining patients had for at least six months
been given interferon beta (108 patients on interferon
beta-1a, 7 on interferon beta-1b).
Thirty-ﬁve healthy participants (18 female) were also
included in the analysis for comparison. The mean age
of the normal volunteer (NV) group was 38.31 10.97
years (range 22–57 years). All subjects agreed to partic-
ipate in the study by signing a written informed con-
sent, and the ethical committees of the participating
institutions had previously approved the protocol.
Magnetic resonance imaging studies
The magnetic resonance imaging (MRI) protocol
included two interleaved sets of 16 slices each covering
the whole brain, which were obtained at 1.5 T (Intera,
Philips Medical Systems, the Netherlands), sampling
the brain at a total of 32 contiguous levels. Each of
the two sets included conventional spin-echo sequences
providing T1w (520/15ms TR/TE) and PD/T2w (1800/
15–90ms TR/TE) 4 mm thick axial images (24cm FOV,
256 256 acquisition matrix).
Voxel-based morphometry analysis
The MRI volumes were preliminarily segmented into
GM, normal and abnormal WM, and cerebrospinal
ﬂuid (CSF) using a fully automated relaxometric
method described in detail elsewhere,
1,14 which pro-
vides the binary maps of normal-appearing GM,
normal-appearing WM, abnormal WM (providing the
T2-w lesion load) and CSF. A previous work that
assessed the accuracy of segmentation of both nor-
mal and abnormal tissues demonstrated a lack of
a LL-associated bias in the measure of brain tis-
sue volumes (100% recovery of GM volume, with a
non-signiﬁcant correlation between GM volume
and LL).
1
The volumes of GM and total WM (hereinafter WM
indicates the sum of both normal-appearing and abnor-
mal WM) were analysed, using optimized VBM analy-
sis,
10,15 to assess both regional diﬀerences between the
NV and MS groups, and correlations with EDSS and
LL in the MS group.
The VBM was performed using the Statistical
Parametric Mapping software (SPM5, Wellcome
Department of Cognitive Neurology, London, UK,
http://www.ﬁl.ion.ucl.ac.uk/spm)
16 running under
MATLAB version 6 (the Mathworks, Inc.,
Massachusetts, USA). Details of the protocol for opti-
mized VBM as applied to segmented volumes has been
described in detail elsewhere.
1
Brieﬂy, for each of the two analysed types of brain
tissue (GM and WM), preprocessing included the fol-
lowing steps:
– Normalization of the GM and WM maps of each
participant to the MNI (Montreal Neurological
Institute) space using the SPM5 mean GM and WM
templates with a 12-parameter aﬃne model without
any nonlinear component.
17 Nonlinear components
were not used for template creation in order to pre-
serve group aﬃne geometry.
18
– Creation of GM and WM templates speciﬁc for site
and group, which were obtained by averaging the
corresponding roughly normalized brain tissue
volumes obtained in the previous step, and by
46 Multiple Sclerosis 16(1)subsequent smoothing with a Gaussian ﬁlter of 8mm
full-width at half-maximum (FWHM).
– Non-linear normalization of the original GM and
WM maps to the corresponding site- and study-
speciﬁc templates with 16 non-linear iterations
using 6 8 6 basis functions to account for global
shape diﬀerences.
19 Normalized images were
resampled by trilinear interpolation to 1 1 1mm
3
voxel size.
– The resulting normalized images were then modu-
lated by multiplying the GM and WM voxels by
the Jacobians derived from the corresponding spatial
normalization parameters, to preserve the amount of
the speciﬁc tissue in each voxel.
10
– Finally, the modulated images were smoothed with a
12mmFWHMisotropicGaussianﬁltertoreducecon-
founding by individual variations in gyral anatomy
and to render the data more normally distributed as
per the Gaussian random ﬁeld model underlying the
statistical process used for adjusting p-values.
17
Statistical analysis
The eﬀect of the disease on global brain tissue volumes
was preliminarily tested, separately for GM, WM and
CSF, by stepwise multiple regression analysis using
SPSS (SPSS Inc., Chicago, Illinois, USA). Total intra-
cranial volume (ICV, the sum of GM, WM and CSF),
age and sex were entered ﬁrst into the model to account
for the possible eﬀects of these variables. Subject group
(NV versus MS) was then entered to explore the eﬀect
of the disease. Subsequently, LL, EDSS and DD were
entered to test for the possible eﬀect of these variables
on global brain tissue volumes in MS patients. The sig-
niﬁcance level was set to 0.05, and corrected for multi-
ple comparisons according to Bonferroni.
To search for regional correlations between brain
tissue volumes and clinical variables, normalized modu-
lated GM and WM volumes were analysed separately at
voxel level using a generalized linear model, with correc-
tion for multiple comparisons based on the random
Gaussianﬁeldtheory,
16includingageandsexasnuisance
regressors (confounding covariates) in an analysis of cov-
ariance (ANCOVA), to take into account their eﬀect on
brain tissue volumes. The ICV was included in the model
to normalize for head size.
Priortoregressionanalysis,scanswerethresholdedat
aﬁxedintensityvalueof25toreducetheinﬂuenceofany
remaining non-brain tissue. Correlations for GM and
WM were assessed separately versus group (NV or
MS), EDSS, LL and DD. For each correlation both
direct and inverse contrasts were probed. A p-value of
0.05FWEFamily-wiseerror-correctedatvoxellevelwas
used for comparisons between NV and MS patients.
Correlations between GM or WM and EDSS, LL
and DD were examined only in regions found pre-
viously to be abnormal in the MS patient group. For
this purpose, an inclusive mask was built using the con-
trol versus patient statistical map with a more lenient
statistical threshold of p<0.05, corrected for false dis-
covery rate.
20 Within this mask, the clusters were con-
sidered signiﬁcant at p<0.05, corrected for multiple
comparisons at the cluster level.
Results
The mean LL was 6.8 9.28cc (mean SD, range
0–46.0cc). Analysis of the global tissue volumes of
our patient population showed signiﬁcantly decreased
GM volume (45.9 3.7% and 47.6 3.7% of ICV
respectively for MS patients and NV, p<0.05 on mul-
tiple regression analysis) and WM volume (37.1 3.1%
and 38.9 2.2%, p<0.005), as compared with NV,
and a correspondingly signiﬁcant increase in CSF
(17.0 5.4% and 13.5 3.3%, p<0.0005).
When assessing the correlation of global tissue
volumes with clinical parameters, we found a signiﬁcant
linear correlation of GM loss with LL (p¼0.001), while
it only approached signiﬁcance when tested versus DD
(p¼0.04) and EDSS (p¼0.06). The WM loss corre-
lated signiﬁcantly with DD (p<0.01), LL
(p<0.00005) and EDSS (p<0.0001). The volume
of CSF correlated with DD (p<0.005), LL
(p<0.000005) and EDSS (p<0.0005).
Table 1 reports the clusters of signiﬁcant GM loss in
MS patients, compared with NV. For each cluster, the
extension and the corresponding Brodmann Areas
(BA) in which local maxima are located, along with
the coordinates in the Talairach space,
21 and the T
level of the most signiﬁcant voxel are reported.
In RR-MS, loss of GM involves preferentially the
left fronto-temporal cortex and precuneus, as well as
the anterior cingulate gyrus and the caudate nuclei
bilaterally, and to a minor extent the right fronto-
temporal cortex and right parietal lobule. The VBM
analysis of WM indicated preferential areas of WM
loss in RR-MS bilaterally in the periventricular regions
in the temporal lobes, juxtacortical insular regions,
extending posteriorly through the internal capsule to
the thalami, and to the splenium of the corpus
callosum (Figure 1). The inverse contrast (MS greater
than NV) did not result in any signiﬁcant region
for either GM or WM.
Regions of GM loss that showed a signiﬁcant linear
correlation with EDSS are shown in Figure 2 and sum-
marized in Table 2, and include the primary motor and
somatosensory areas and the middle frontal gyri bilat-
erally, with extension to the middle temporal gyrus in
the right hemisphere.
Prinster et al. 47In Figure 3 is shown the map of the regions, indicat-
ing a signiﬁcant correlation between WM loss and
EDSS (in green) along with the regions of GM loss
correlating with EDSS (in red). Regions of WM loss
correlating with EDSS are located bilaterally in the
juxtacortical regions adjacent to the primary motor
cortex and lower temporo-parietal regions, in the brain-
stem (both pyramidal tracts and tegmentum) and in the
anterior part of the corpus callosum.
Correlations between regional GM loss and lesion
load (LL) are depicted in Figure 4 and summarized in
Table 3. Regions of GM loss that correlate signiﬁcantly
with LL are distributed symmetrically in the caudate
heads, the parahippocampal and cingulate gyri, motor
cortex and insula.
Regions of WM loss that correlate with LL are
reported in Figure 5. These include the corpus callo-
sum, with more extensive involvement of the genu
and splenium, the latter extending bilaterally to the
juxtacortical ﬁbres abutting the precuneus/posterior
cingulate, thalamocapsular WM, and the deep tempo-
ral white matter bilaterally.
Assessment of the correlations between either GM
or WM loss and DD did not result in any signiﬁcant
cluster.
Discussion
The aim of this work was to assess the possible correla-
tions between regional GM and WM loss and clinical
parameters, including EDSS score (an index of disabil-
ity), total LL (an index of disease severity) and DD, in a
large group of patients with RR-MS.
The demonstration of global reduction in GM and
WM volumes in RR-MS is in line with previous ﬁnd-
ings of GM and WM atrophy,
22 and the preliminary
assessment of regional GM volume in RR-MS, as com-
pared with NV, conﬁrmed previous ﬁndings, obtained
using the same optimized VBM approach in a smaller
patient group, of a preferential involvement of frontal
regions.
1
Additional assessment of WM volumes showed a
more widespread loss, involving, besides periventricular
and medial temporal WM (reﬂecting ventricular
enlargement, which is predominant in RR-MS),
23
pyramidal tracts extending from juxtacortical ﬁbres
adjacent to the sensorimotor cortex, through thalamo-
capsular regions to the cerebral peduncles.
The signiﬁcant loss of brain tissue in the thalamic
region, with a signiﬁcant correlation with LL, may
actually reﬂect brain tissue loss in both pyramidal and
Table 1. Clusters of significant grey matter loss in patients with relapsing–remitting multiple sclerosis relative to controls. For each
cluster, the extension and the corresponding Brodmann areas (BA) in which local maxima are located, along with the coordinates in
the Talairach space and the T level of the most significant voxel, are reported
Coordinates (mm)
Region Side BA N. voxel T x y Z
Precentral gyrus L 4/6 52739 7.50  30
 32
 35
 26
 20
 13
55
12
45
Insula/claustrum R 13 3045 7.07 33
44
 18
 9
14
0
Caudate head L/R n/a 1267 6.85  3
 7
10
17
3
2
Cingulate gyrus bilateral 24/31 10571 6.28  6
5
 9
24
31
 23
21
13
37
Middle frontal gyrus R 8 1298 6.13 23 18 39
Middle frontal/precentral gyrus R 9/8 4743 5.95 45
39
41
12
26
24
33
48
38
Precentral/postcentral gyrus R 6/3 1285 5.47 37
42
 6
 16
38
51
Inferior/superior
Parietal lobule
R 40/7 2027 5.36 40
36
34
 41
 48
 47
53
47
61
Superior temporal gyrus L 9/8 367 5.05  48  52 30
n/a, not applicable.
48 Multiple Sclerosis 16(1)thalamic regions, because with the present segmenta-
tion technique most of the lateral thalamus is seg-
mented as WM. Thalamic atrophy has been found in
many studies of MS, and seems to be present already in
the very early stages of MS, including clinical isolated
syndrome (CIS).
24
Give that the thalami are composed of GM nuclei
interspersed among WM tracts, classiﬁcation even with
a multiparametric approach is challenging, and studies
focusing speciﬁcally on this region, e.g. using diﬀusion
tensor-based segmentation,
25 are required to disentan-
gle the relative contributions of these anatomical struc-
tures to local loss of brain tissue.
Previous work probing the correlations between
global brain tissue volumes and indexes of disease
severity have shown that global GM loss correlates
weakly with EDSS in RR-MS in transversal studies,
26
while a few longitudinal studies have suggested that
patients who show sustained progression in disability
(as measured by EDSS) present a signiﬁcantly faster
progression of the atrophy compared with patients
with relatively stable disease.
27–29 In our patient popu-
lation we conﬁrmed the presence of a correlation
between EDSS and global brain atrophy, as measured
by increased CSF, which was sustained by a reduction
of global WM and (to a lesser extent) GM volumes.
When testing correlations of regional loss of GM
with disease severity using VBM, motor areas showed
a preferential correlation with EDSS bilaterally. These
results conﬁrm and extend previous observations from
studies of cortical thickness, in small groups of MS
patients with mixed disease course, that suggested a
reduction in regional cortical thickness at the level of
the motor areas in patients with higher disability scores
as compared with NV,
2 with a rate of GM thickness
reduction that was more pronounced in the parietal and
precentral cortex in patients with a more aggressive dis-
ease course, compared with stable patients.
5
A previous study in a smaller cohort of patients with
pure RR-MS, which used the same methodology as the
present study to analyse regional GM volume loss,
failed to detect signiﬁcant regional correlates of
EDSS.
1 This was probably attributable to the reduced
sample size and the smaller span of EDSS values
(51 patients with an EDSS range of 1.5–4.5, versus
128 patients with EDSS range 1.0–6.0).
Another study that focused on correlates of regional
GM loss in a large cohort of patients with pure
Figure 1. Axial sections (first row, patient’s left side is on the observer’s left side), sagittal sections of the left (bottom left) and right
(bottom right) hemispheres, and coronal section (bottom row, centre) from selected levels of a normal subject T1-weighted volume
(in greyscale). The regions of significant white matter loss in patients with multiple sclerosis as compared with controls are overlaid in
colourscale. Bilaterally, in the periventricular regions in the temporal lobes, juxtacortical insular regions, extending posteriorly through
the internal capsule to the thalami, and the splenium of the corpus callosum are involved.
Prinster et al. 49RR-MS, using a technique based on the assessment of
cortical thickness to look for correlations with LL and
disability in 425 patients, found a higher rate of thin-
ning per unit increase in EDSS in the prefrontal regions
bilaterally and in the anterior cingulate regions.
4 The
authors suggested that the poor correlation of cortical
thinning of the premotor and motor areas with EDSS
and LL might be due to the relatively mild impairment
of their patients, with a high prevalence of patients at
relatively early stages of the disease in the sample.
The present data, however, do not support this
hypothesis because correlation of primary sensorimotor
areas with EDSS was present and sizeable, despite the
smaller EDSS range (1–6 as compared to 0–8 in the
cohort published by Charil
4) and smaller LL (up to
46.0cc, compared with 78.6cc).
Diﬀerences in the techniques used to assess atrophy
(cortical thickness versus VBM) might contribute to the
diﬀerent results. In particular, studies of cortical thick-
ness may be more sensitive to variations in GM regions
Figure 2. Regions exhibiting a significant correlation between grey matter loss and Expanded Disability Status Scale (p<0.05
corrected for multiple comparisons at cluster level, i.e. t score >3.16) in patients with relapsing–remitting multiple sclerosis are
overlaid in colour on to the surface of a single subject normalized brain.
The primary motor and somatosensory areas, and the middle frontal gyri are involved bilaterally, with extension to the middle
temporal gyrus in the right hemisphere.
Table 2. Clusters of significant grey matter loss that correlate with Expanded Disability Status Scale in patients with relapsing–
remitting multiple sclerosis. For each cluster, the extension and the corresponding Brodmann areas (BA) in which local maxima are
located, along with the coordinates in the Talairach space and the T level of the most significant voxel, are reported
Coordinates (mm)
Region Side N. voxel T x y Z
Precentral gyrus/postcentral gyrus R 41162 4.83 37
26
 32
 24
53
52
Frontal lobe – paracentral lobule R 13  37 44
Precentral gyrus/postcentral gyrus L 18416 4.73  53
 44
 15
 15
34
40
Inferior parietal lobule L  40  39 57
50 Multiple Sclerosis 16(1)with stronger morphological variability, such as the
frontal cortex,
30,31 while more stable regions of the
brain may be better explored using VBM. However,
to the best of our knowledge, comparative studies
using both techniques are not currently available, and
further work is needed to assess diﬀerences between
these two techniques.
Additionally, criteria for patient selection may have
played a role in determining diﬀerent results; for exam-
ple, current use of disease modifying therapy (DMT)
was not an exclusion criterion in the present study,
while previous use of immunosuppressors or experi-
mental immunomodulatory therapies was not an exclu-
sion criterion in the aforementioned paper.
Regarding correlation of GM loss and LL, the cur-
rent results extend the previous ﬁndings of a correlation
between GM loss and LL at the level of both caudate
heads, showing areas of signiﬁcant correlation also in
the cingulate gyri, sensorimotor regions and temporal
lobes, including the insulae.
1
Interestingly, deep GM atrophy has been related to
global LL also in primary and secondary progressive
forms of the disease, as opposed to regional cortical
atrophy which has been related in the same forms to
corresponding lobar lesion loads.
6
In that same study, however, Ceccarelli et al.
6
demonstrated in RR-MS a correlation of thalamic atro-
phy with LL, which, owing to the diﬀerences in the
segmentation techniques, may be reﬂected partly by
the signiﬁcant clusters that were detected in the present
study in the thalamo-capsular regions in the VBM ana-
lysis of the WM. Also, diﬀerences in data acquisition
may contribute to diﬀerent sensitivities. For the present
work we used segmented two-dimensional sequences,
which in principle may limit the accuracy of the
method as compared to the use of three-dimensional
sequences with isotropic resolution. However, it
should be considered that the preprocessing for VBM
involves a smoothing three times larger than the slice
thickness (12mm FWHM), thus making the use of
4mm sections unlikely to aﬀect the results of VBM.
The use of VBM to assess regional loss of WM
allowed demonstration of a signiﬁcant correlation with
EDSS in the WM, which stemmed from the motor areas
bilaterally and followed the pyramidal tracts down to the
brainstem, thus supporting the hypothesis that motor
neurons are more severely damaged as disability
progresses.
In RR-MS, a correlation between motor disability
and spinal cord atrophy has been previously demon-
strated,
32 which may be in turn related also to atrophy
of the pyramidal tracts. However, further work is needed
to explore this possible mechanism, and to assess possi-
ble speciﬁc clinical correlates of pyramidal tract atrophy.
It is of note that DD showed a weaker correlation
with global atrophy, compared with LL and EDSS,
Figure 3. Regions of white matter loss (in green) that correlate with Expanded Disability Status Scale in patients with relapsing–
remitting multiple sclerosis together with regions of grey matter loss (in red) for comparison (p<0.05 corrected for multiple
comparisons at cluster level, i.e. t score >3.16). White matter loss is located bilaterally in the juxtacortical regions adjacent to the
primary motor cortex and lower temporo-parietal regions, in the brainstem (both pyramidal tracts and tegmentum), and in the
anterior part of the corpus callosum.
Prinster et al. 51without any regional speciﬁcity in the VBM analysis.
This may be due to both the diﬃculty in deﬁning the
time of disease onset based on the anamnesis, as well as
the intrinsic inter- and intra-subject variability of dis-
ease progression in RR-MS.
A limit of our study lies in the heterogeneity of the
patient group in terms of clinical variables, which facili-
tated the detection of potential correlates of EDSS and
DD, but in turn limited the current approach to the study
of the common patterns of brain tissue involvement
across a heterogeneous population, while correlations
that may be present only in MS subgroups (e.g. early
MS, benign MS) may have remained undetected.
Furthermore, the presence of atrophy in the early
phases of the disease, including CIS,
24 may limit the
sensitivity of correlation analysis. The correction for
age, here included both as a ﬁrst step in the multiple
regression analysis of global tissue volumes, and as a
nuisance covariate in the VBM analysis, to allow for
the strong correlation of brain tissue volumes with
age,
15 may have hindered detection of an eﬀect of
DD on atrophy within the constraints of the general
linear model generalized linear model.
Conclusions
In RR-MS, we have conﬁrmed a direct correlation
between disease severity and brain tissue loss (both
GM and WM) in the motor system, while LL correlates
of brain tissue loss mainly aﬀect highly interconnected
Figure 4. Regions of significant correlation between grey matter loss and lesion load (p<0.05 corrected for multiple comparisons at
cluster level, i.e. t score >3.16) in patients with relapsing–remitting multiple sclerosis are overlaid in colour on to the sections of a
normal subject T1-w images and are symmetrically distributed in the caudate heads, the parahippocampal and cingulate gyri, motor
cortex and insula.
52 Multiple Sclerosis 16(1)Figure 5. Regions of white matter loss (in green) that correlate with lesion load in patients with relapsing–remitting multiple sclerosis
together with regions of grey matter loss (in red) for comparison (p<0.05 corrected for multiple comparisons at cluster level, i.e. t score
>3.16). They include the corpus callosum, with more extensive involveme n to ft h eg e n ua n ds p l e n i u m ,t h el a t ter extending bilaterally to the
juxtacortical fibres abutting the precuneus/posterior cingulate, thalamocapsular white matter, and the deep temporal white matter bilaterally.
Table 3. Grey matter clusters exhibiting a significant negative correlation with lesion load in patients with relapsing–remitting
multiple sclerosis. For each cluster, the extension and the corresponding Brodmann areas (BA) in which local maxima are located,
along with the coordinates in the Talairach space and the T level of the most significant voxel, are reported
Coordinates (mm)
Region Side BA N. voxel T xyZ
Caudate head L/R n/a 8284 7.20  10
6
19
15
2
2
Parahippocampal gyrus L/R 30/36 8375 5.95 18
 10
 43
 38
 13
 10
Cingulate gyrus L/R 31/24 5444 5.86 11
 4
 21
 16
36
36
Precentral/postcentral gyrus R 3/4 19487 5.59 39
48
 21
 13
48
48
Insula
Transverse temporal gyrus
L1 3
42
8733 5.55  35
 64
 15
 16
15
10
Insula
Postcentral gyrus
R1 3
40
5574 5.50 36
52
 20
 28
11
20
Precentral gyrus L 4/6 16980 5.0  26
 44
 11
 16
51
41
Prinster et al. 53subcortical structures, including the caudate nuclei and
thalami.
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